Leishmaniasis

Clin Med (Lond). 2011 Oct;11(5):492-7. doi: 10.7861/clinmedicine.11-5-492.

Abstract

Leishmaniasis is an uncommon infectious disease in the UK with a variety of clinical presentations. Physicians should remember to consider this diagnosis in patients with an appropriate travel history (including the Mediterranean basin) and seek help with diagnostics from a specialised parasitology laboratory. Treatment regimens may be unfamiliar to the general physician, and thus should also be discussed with an expert.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Antimony Sodium Gluconate / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Humans
  • Immunocompromised Host
  • Leishmaniasis, Cutaneous / diagnosis*
  • Leishmaniasis, Cutaneous / drug therapy*
  • Leishmaniasis, Visceral / diagnosis*
  • Leishmaniasis, Visceral / drug therapy*
  • Leishmaniasis, Visceral / epidemiology
  • Male
  • Middle Aged

Substances

  • Antiprotozoal Agents
  • Amphotericin B
  • Antimony Sodium Gluconate